4D-CT for Pancreatic Adenocarcinoma in Radiotherapy Simulation

Completed

Conditions studied: Pancreatic Adenocarcinoma

In brief

The primary objective is to study the feasibility and efficacy of individually optimized CE 4D-CT for PDA in radiotherapy simulation.

Key facts

Study ID

NCT01764659

Run by

University of Maryland, Baltimore

People needed

14

Starts

2013-07-01

Expected to finish

2014-10-01

Last updated by the study team

2020-03-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients 18 years old or older
• Patients with PDA who have not had surgical removal of their tumor and who are planned for treatment with radiotherapy in the Radiation Oncology Department at the University of Maryland.
• Patients who have signed the contrast consent form and have been recommended by physicians to have contrast-enhanced CT scans.
• Patients who have signed the consent form for this study

You may not qualify if…

• Pregnant or breast-feeding women.
• Patients with severely decreased renal function19-21.
• Patients with known severe allergic reactions to contrast.
• Patients who have difficulty lying flat on their back for extended periods of time.
• Patients with breaths per minute (BPM) rate less than 10, due to the limitation of 4D-CT image reconstruction software.

Where it is running

• Ummc Msgcc — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.